Partners in Innovation
Guerbet is actively involved in many partnerships with first-rate academic research centers, but also with companies with which potential synergies can be envisaged.
In the MRI field Guerbet is a major player in the Iseult project. Run in conjunction with the French Atomic Energy Commission (CEA), the Iseult project, initiated in 2006, aims to develop new contrast agent for imaging brain disease using high magnetic-field MRI.
In the IRT field Guerbet is involved in HECAM project.
HECAM (HEpatocellular CArcinoma Multi-technological) aims to develop screening tools, diagnosis and treatment of primary liver cancer.
These programs are all supported by BPI France.